$6.50
-0.58-8.26%
Ult. Agg.: Oct 26, 9:30 AM
Moleculin Biotech (MBRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.55 | $-1.67 | $-6.77 | $-5.50 |
| Actual | $-1.40 | $-3.54 | $-26.06 | $-17.00 |
| Surprise | +9.68% | -112.0% | -284.9% | -209.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-9.07 | $-8.59 |
| Revenue | ||
| Consensus | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-1.40 | $-1.55 | 9.68 % |
| Q1 | May 15, 2026 | $-3.54 | $-1.67 | -112.0 % |
| Q4 | Mar 19, 2026 | $-26.06 | $-6.77 | -284.9 % |
| Q3 | Nov 13, 2025 | $-17.00 | $-5.50 | -209.1 % |